Urology News Archive
In a small study, sunitinib recipients who took royal jelly, a substance produced by worker honeybees for queen bees, were less likely to experience fatigue and anorexia than those who took placebo.
In a Spanish study, the highest vs lowest tertile of dietary zinc intake was associated with a significant 66% increased relative risk of low-grade prostate cancer.
For example, men with a baseline NLR below 2.5, patients who received abiraterone had a significant 28% decreased risk of death.
Study of Canadian men looked at the association between prostate cancer and participants' socioeconomic position during childhood/adolescence and early and late adulthood.
In a study, visual registration in conjunction with image fusion resulted in the highest detection rate of clinically significant prostate cancer.
For this study, the authors identified randomized controlled trials (RCTs) that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.
Black men with Gleason 6 prostate cancer had a 1.5- to 2.0-fold increased risk of dying from their cancer compared with nonblack men, according to a new study.
Researchers found no significant difference in 30-day postoperative complications between patients who received neoadjuvant chemotherapy and those who did not.
Statin use by men receiving androgen deprivation therapy for advanced PCa was associated with decreased risk of overall and cancer-specific mortality.
New study finds a prevalence of benign pathologic findings after PN of 30.9%.
Researchers theorize that KPNA2 expression could be used in the future to stratify risk groups among patients with renal cell carcinoma (RCC).
Mean 2.9 years gained after 23 years of follow-up among men with localized prostate cancer
When 121 regions were considered together, VHA care was better for 14 of 15 outcome measures
In a small trial, patients receiving 300 U and 500 U of intravesical abobotulinumtoxin A experienced reductions in nocturia episodes at 12 and 24 weeks.
Sildenafil and tadalafil not approved to be sold over the counter and are being sold illegally.
A review article examines the challenges in pathologic staging and grade reporting for patients with renal cell carcinoma.
In a study, percutaneous tibial nerve stimulation reduced nocturia episodes by 0.8 on average.
41% are not at all familiar with personalized medicine; only 5% say they are very familiar.
Nocturia improved 43% in patients receiving oral desmopressin alone and 64.3% in those receiving desmopressin and an alpha-blocker.
Study authors developed a Markov model with health states based on daily urinary incontinence episodes (UIEs) to compare the cost-effectiveness of onabotulinumtoxinA, implantable sacral nerve stimulation devices, percutaneous tibial nerve stimulation, anticholinergic medications, and mirabegron versus BSC for the management of refractory OAB.
UROPP reduces opioids prescribed after gynecologic, abdominal surgery without negative effects.
Hypogonadism and serum testosterone evaluation nearly doubled the odds a man would undergo varicocelectomy.
IBD is associated with a nearly 5-fold increased risk of prostate cancer, study finds.
Patients with muscle-invasive bladder cancer had a 22% decreased risk of disease progression if they received neoadjuvant rather than adjuvant chemotherapy, a study found.
More than half of UK specialists surveyed said measuring testosterone levels in patients with nonmetastatic prostate cancer was not their routine practice.
Risk for patients in rivaroxaban group reduced during the on-treatment period
In a study, the rate of deep vein thrombosis in treated hypogonadal men was just 0.8% over 2 years of follow-up.
Method evaluating cells collected from urine shows 94% diagnostic accuracy.
Lymph node dissection did not influence overall survival even among patients with clinically positive nodal disease.
Prior to starting Xyosted, the patient's baseline cardiovascular risk should be considered and blood pressure should be adequately controlled.
Men with Gleason score 9 to 10 prostate cancer derive no significant survival benefit from androgen deprivation therapy.
Well demarcated hypoechoic areas in suspicious regions on MRI identify men more likely to have Gleason 7 or higher prostate cancer found on biopsy.
Overweight and obesity, diabetes, and postoperative complications increase the likelihood of being readmitted within 30 days of hospital discharge among radical cystectomy patients.
In a study, taking lipid-lowering drugs for 10 or more years was associated with a 32% lower risk prostate cancer.
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
Patients whose radical prostatectomy was delayed more than 6 months had a nearly 2-fold increased risk of biochemical recurrence, a study found.
Targeted patient-centered intervention reduces nonadministration of pharmacologic prophylaxis.
Men with very high-risk (VHR) PCa are more likely to have adverse pathologic features and outcomes after radical prostatectomy than those with high-risk but not VHR PCa.
Desmopressin reduced the number of nocturnal voids by 0.85 compared with placebo.
Study compared radical prostatectomy plus adjuvant EBRT or ADT, or both, with a triple combination of EBRT, brachytherapy, and ADT for Gleason score 9-10 prostate cancer.
Meta-analysis suggests that testosterone treatment enhances mood in hypogonadal and eugonadal men.
Study of men who underwent salvage radical prostatectomy for radiorecurrent prostate cancer found a 10-year rate of biochemical progression-free survival of 33%.
Many patients with extraprostatic extension on biopsy experience biochemical recurrence after surgery and require early multi-modal therapy.
Men with nocturia have a 1.4-fold greater risk of death than men without nocturia, after adjustment for age and major comorbidities.
The antidiuretic effects of desmopressin are mediated by stimulation of vasopressin 2 (V2) receptors, thereby increasing water reabsorption in the kidneys, and reducing urine production.
Poll finds that few women report talking to their physician about urinary leakage.
In addition to health care factors, issues outside of treatment may affect cancer death rates.
Lowering nocturnal urine production and enabling patients to void consistently at capacity may ease nocturia in men with low bladder capacity.
In a study, heart failure was nearly twice as likely to develop among ADT recipients compared with non-recipients.
Patients use 0.53 more pills for every additional opioid pill prescribed; pain also tied to consumption
For men with nocturnal polyuria, the rate of urine production dropped off as the night progressed.
In a study, older men with difficulty walking or climbing stairs reported better physical function after testosterone therapy.
Poor clinical outcomes linked to extended spectrum cephalosporin-resistant Enterobacteriaceae.
Avelumab plus axitinib is associated with longer progression-free survival compared with sunitinib as first-line therapy in patients with advanced renal cell carcinoma.
Higher risk for premature birth, low birth weight, low Apgar score seen with older paternal age.
As stearic acid and total fatty acid intake increased from one quintile to the next, prostate risk increased by 23% and 21%, respectively.
In a recent meta-analysis, testosterone therapy was not associated with major or minor adverse cardiovascular events.
In a study, reduced mortality was found among TRT users with type 2 diabetes after adjustment for cardiovascular risk factors.
Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation
To investigate the risk of cardiovascular adverse effects associated with this antibiotic class, researchers conducted a systematic review, meta-analysis, and network meta-analysis using studies identified through a search of MEDLINE, EMBASE, and the Cochrane Library.
UGN-1 is an investigational formulation of mitomycin, delivered to patients using standard intravesical catheters.
Local control, cancer-specific survival at 2 years similar for patients with solitary, bilateral kidneys
New multidisciplinary guideline for early-stage prostate cancer developed by 3 professional societies.
Results from phase 2 study in patients with multidrug-resistant Gram-negative uropathogens.
At the time of diagnosis of renal cell carcinoma, blacks had 33% lower odds of regional disease compared with whites, a new study found.
The 3-year survival rate was 81% for patients who underwent EBRT plus standard care vs 73% for those who had standard care alone.
Trials show high survival rates, freedom from recurrence for low-, intermediate-risk prostate cancer.
3 percent of midurethral mesh slings for stress urinary incontinence removed by 9 years
Radiation dose not impacted with light or moderate use of skin treatments, regardless of beam energy, incidence
Long-term data show a local disease recurrence rate of 2.1% at 10 years.
Long-term oncologic outcomes of patients with sporadic RCC who underwent robotic tumor enucleation suggest the procedure is safe.
Among prostate cancer patients, androgen deprivation therapy (ADT) recipients are 34% more likely to experience any osteoporotic fracture than those who do not receive ADT.
New findings could help explain why men of African ancestry are more likely than white men to die from prostate cancer.
International Continence Society (ICS) standards offer useful guidance for nocturia management, according to the authors of a new report.
A midlife PSA value above the 90th percentile was associated with greater risk of total and aggressive prostate cancer in black men.
Older patients benefit from treatment of superficial bladder cancer even if they have multiple chronic conditions, a new study suggests.
In a study, advanced glycation end products were significantly higher in people with nocturia.
In a study, androgen deprivation therapy did not increase risks for vascular or any other form of dementia among men with prostate cancer who underwent definitive radiation therapy.
In a recently published study, external beam radiation therapy for localized prostate cancer was associated with a 35% increased risk of bladder cancer compared with radical prostatectomy.
In a study, nighttime voiding significantly correlated with smaller dips in nocturnal blood pressure.
Having 3 or more voids per night was associated with 72% excess death risk.
New study reveals a 29% prevalence of erectile dysfunction, a proportion higher than that of the general population.
A combination of age, comorbidity, and PSA doubling time can risk stratify cause of death among men with non-metastatic castration-resistant prostate cancer, study suggests.
Myocardial infarction following the kidney stone procedure is twice as likely among patients with 3 to 4 components of metabolic syndrome vs no components.
Men in Puerto Rico have higher prostate cancer incidence rates than other Hispanics, non-Hispanic whites.
In a study, men with prostate cancer who received androgen deprivation therapy did not have a lower subsequent risk of developing bladder cancer.
Depletion of Lactobacillus iners in the bladder appears to increase the risk of urinary tract infection following urogynecologic surgery, study finds.
Study of patients with clinical T1a renal cell carcinoma shows that those who undergo renal mass biopsy have only a 1.2% rate of upstaging to pT3a perinephric fat involvement.
Increased facility use of mesh augmentation impacts risk of repeat prolapse repair surgery
At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years
Propensity score-matched analysis shows that radical and partial nephrectomy for cT1 renal cell carcinoma are associated with similar cancer-specific and all-cause mortality, a study found.
During a 12-month study, women who drank 1.5 L of water daily in addition to their usual fluid intake reduced their mean number of cystitis episodes nearly by half.
Medium-term oncologic results are comparable to those of radical prostatectomy and radiation therapy, according to investigators.
Older age, male sex, and higher T stage are associated with an increased risk of having bone metastases at initial diagnosis of renal cell carcinoma, study finds.
Only 11% of private insurers in the United States cover prostate MRI in biopsy-naïve patients with suspect prostate cancer.
Correlates of receiving prescription include female sex, specific physician specialty, geographic region
Radical prostatectomy plus adjuvant radiotherapy is associated with better cancer-specific and overall survival than radiotherapy plus androgen deprivation therapy in patients with locally or regionally advanced prostate cancer.
Development of kidney stones is 6.2-fold more likely among patients with persistent hyponatremia than those without a history of hyponatremia.
Renal and Urology News Articles
- Younger Men With High-Grade PCa Less Likely to Die After RP Than RT
- Roxadustat Effective in Chronic Kidney Disease Patients With Anemia
- Novel Albuminuria Endpoints May Improve CKD Progression Trials
- Molidustat Promising for Renal Anemia
- Global Demand for Bladder Cancer Treatment Threatens Supply in 2019
- Low Vitamin D Tied to Risk for Renal Hyperfiltration in Healthy Adults
- Novel Albuminuria Endpoints May Improve CKD Progression Trials
- Younger Men With High-Grade PCa Less Likely to Die After RP Than RT
- Overactive Bladder Linked to Prostate Cancer ADT
- Second-Line Antidiabetic Meds May Impact Cardiovascular Risk
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)